Cellular and humoral mechanisms in graft rejection
Blanco, A.; Gómez-Carrasco, J.A.
Anales Espanoles de Pediatria 31(Suppl 39): 123-126
1989
ISSN/ISBN: 0302-4342 PMID: 2490314 Document Number: 328339
Document emailed within 1 workday
Related Documents
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793Sun, Q.; Li, L. 2006: Graft loss associated with late humoral rejection after renal transplantation Clinical Transplants 2006: 521-525
Lee, I.; Constantinescu, S.; Gillespie, A.; Swami, A.; Birkenbach, M.; Leech, S.; Silva, P.; Karachristos, A.; Daller, J.A.; Sifontis, N.M. 2009: Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line? Clinical Transplants 2009: 425-429
1975: Effector mechanisms in graft rejection Transplantation proceedings 7(1 Suppl 1): 243-333
Knosalla, C.; Grauhan, O.; Muller, J.; Pfitzmann, R.; Fietze, E.; Cohnert, T.; Volk, H.D.; Hetzer, R. 2000: Intramyocardial electrogram recordings (IMEG) for diagnosis of cellular and humoral mediated cardiac allograft rejection Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 6(2): 89-94
Bryan, B.A.; Henry, M.L.; Ferguson, R.M. 1992: Renal xenografts perfused ex vivo require both humoral and cellular components to undergo hyperacute rejection Transplantation Proceedings 24(2): 609
Yasunaga, C.; Cramer, D.V.; Chapman, F.A.; Wang, H.K.; Barnett, M.; Wu, G.D.; Makowka, L. 1993: Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium Transplantation Proceedings 25(3 Suppl. 2): 65-66
Malchow, H. 1972: Inhibiting humoral and cellular mechanisms in the recognition of various transplantation antigens in autoimmune and lymphoproliferative diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 892-895
Ponisovskiy, M.R. 2011: Driving mechanisms of passive and active transport across cellular membranes as the mechanisms of cell metabolism and development as well as the mechanisms of cellular distance reactions on hormonal expression and the immune response Critical Reviews in Eukaryotic Gene Expression 21(3): 267-290
Kirkman, R.L.; Flye, M.W.; Williams, G.M.; Colvin, R.B.; Sachs, D.H. 1979: Evidence for cellular immune mechanisms in hyperacute rejection of renal allografts in miniature swine Transplantation Proceedings 11(1): 790-792
Lordon, R.E.; Wilson, R.L.; Shield, C.F.; Ferrone, S. 1981: Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection Transplantation 32(4): 286-290
Dahlqvist, G.; Horsmans, Y.; Komuta, M.; Coubeau, L. 2019: Acute liver graft cellular rejection after interferon-free antiviral treatment for HCV infection. Is there a risk? a warning about three cases Acta Gastro-Enterologica Belgica 82(1): 53-56
Kirkman, R.L.; Colvin, R.B.; Flye, M.W.; Williams, G.M.; Sachs, D.H. 1979: Transplantation in miniature swine. VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal alografts Transplantation 28(1): 24-30
Hall, B.M.; Roser, B.J.; Dorsch, S.E. 1979: A model for study of the cellular mechanisms that maintain long-term enhancement of cardiac graft survival Transplantation Proceedings 11(1): 958-961
Baldamus, C.A. 1973: Rejection and rejection protection of transplants by humoral antibodies Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 585-588
Frezza, E.E.; Gerunda, G.E.; Fassina, A.; DeFranchis, R.; Biffi, R.; Gurakar, A.; Fagiuoli, S.; Maffei, F.A.; Van Thiel, D.H. 1994: NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation Transplantation Proceedings 26(3): 1626
Martín Mola, E.; Cabarcos Cazón, A.; Imizcoz, J.L.; Pérez Miranda, M. 1980: Humoral and cellular immunopathology of rheumatoid arthritis. II. Quantitative cellular immunity Revista de Medicina de la Universidad de Navarra 24(4): 43-48
Lehtonen, S.R.; Isoniemi, H.M.; Salmela, K.T.; Taskinen, E.I.; von Willebrand, E.O.; Ahonen, J.P.; vWillebrand, E.O. 1997: Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection Transplantation 64(1): 103-107
Donaldson, P.T.; Thomson, L.J.; Heads, A.; Underhill, J.A.; Vaughan, R.W.; Rolando, N.; Williams, R. 1995: IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry Transplantation 60(9): 1016-1023
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675